Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
BRISBANE, Calif., March 09, 2017 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, President and Chief Executive Officer, will be presenting at the Spring 2017 Sidoti Convention, to be held on March 29, 2017 at the Marriott Marquis in Times Square in New York, NY.
Mr. Reinstein is scheduled to present on Wednesday, March 29 at 1:15 PM ET. A live audio webcast and slides of the presentation will be made available at the Investor Relations section of the Company’s website, www.cutera.com.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS: Cutera, Inc. Ron Santilli Chief Financial Officer 415-657-5500 Investor Relations John Mills Integrated Corporate Relations, Inc. 646-277-1254 [email protected]
